Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ACTRN12626000409370) titled 'Safety and Feasibility of Using the Omnipod M AID System with a Novel Combination of Insulin in Adults with Type 2 Diabetes' on April 2.

Study Type: Interventional

Study Design: Purpose: Treatment Allocation: Non-randomised trial Masking: Open (masking not used) Assignment: Other

Primary Sponsor: Edge Trials Limited

Condition: Type 2 diabetes Type 2 diabetes Metabolic and Endocrine - Diabetes

Intervention: This is a multi-arm, non-randomised feasibility study with two participant cohorts. Cohort A: EVOLUTION 2 participants and new T2D participants who have used the Omnipod M System configured for U-100...